ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,848.28
1.55%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. iBio Inc (IBIO)

  7. iBio Inc (IBIO) Noticias

IBIO iBio Inc

1.9519
-0.0781 (-3.85%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
iBio Inc IBIO AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0781 -3.85% 1.9519 18:27:18
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.03 1.95 2.15 1.99 2.03
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
27/3/202406:00GLOBEiBio and AstralBio Announce Transformative AI drug discovery..
26/3/202418:35GLOBEiBio Announces $15.0 Million Private Placement
26/2/202406:59EDGAR2Form 8-K - Current report
26/2/202406:45GLOBEiBio Announces Sale of Preclinical PD-1 Agonist Antibody..
21/2/202415:55EDGAR2Form 8-K - Current report
19/1/202415:36EDGAR2Form 8-K - Current report
16/1/202407:15GLOBEiBio Announces Participation in 23rd Annual PepTalk..
10/1/202412:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202415:30EDGAR2Form 8-K - Current report
04/1/202407:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/12/202306:44EDGAR2Form 8-K - Current report
26/12/202306:15GLOBEiBio Amends and Extends Maturity of Credit Agreement
08/12/202315:17EDGAR2Form 8-K - Current report
06/12/202308:13EDGAR2Form 8-K - Current report
06/12/202307:59EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/202307:00GLOBEiBio, Inc. Announces Pricing of $4.5 Million Public Offering
04/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
30/11/202307:55EDGAR2Form S-1/A - General form for registration of securities..
28/11/202307:36EDGAR2Form 8-K - Current report
27/11/202316:20GLOBEiBio Announces Reverse Stock Split
03/11/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:24GLOBEiBio Further Expands Tech Stack with ShieldTx™; Enhances..
27/10/202315:29EDGAR2Form S-1 - General form for registration of securities under..
26/10/202307:20EDGAR2Form DEF 14A - Other definitive proxy statements
16/10/202315:59EDGAR2Form PRE 14A - Other preliminary proxy statements
10/10/202307:56EDGAR2Form 8-K - Current report
10/10/202307:00GLOBEiBio to Highlight Technology for Advancing Discovery of..
05/10/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202315:34EDGAR2Form 8-K - Current report
02/10/202305:45GLOBEiBio Explains Recent Filing of Registration Statement
29/9/202316:28EDGAR2Form POS AM - Post-Effective amendments for registration..
27/9/202315:31EDGAR2Form 8-K - Current report
27/9/202315:19GLOBEiBio Announces Filing of 2023 Annual Report on SEC Form 10-K
27/9/202315:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/9/202315:05GLOBEiBio Announces Amendment to Credit Agreement with Woodforest
21/9/202307:00EDGAR2Form 8-K - Current report
30/8/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202315:15GLOBEiBio Reports Triple Milestone: In Vivo Proof-of-Concept for..
14/8/202314:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/8/202315:01EDGAR2Form 8-K - Current report
07/8/202308:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/8/202315:47EDGAR2Form 8-K - Current report
28/7/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202307:29EDGAR2Form 8-K - Current report
27/6/202307:00GLOBEiBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO..
12/6/202315:15GLOBEiBio Forges Research Collaboration with the National..

Su Consulta Reciente

AMEX
IBIO
iBio
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados